Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage.
The cellular prion protein (PrP(C)) has been implicated in the development of Alzheimer's disease (AD). PrP(C) decreases amyloid-β (Aβ) production, which is involved in AD pathogenesis, by inhibiting β-secretase (BACE1) activity. Contactin 5 (CNTN5) has also been implicated in the development o...
Main Authors: | Isobel J Whitehouse, J Scott Miners, Elizabeth B C Glennon, Patrick G Kehoe, Seth Love, Katherine A B Kellett, Nigel M Hooper |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3618446?pdf=render |
Similar Items
-
BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging.
by: Elizabeth B C Glennon, et al.
Published: (2013-01-01) -
Cellular prion protein expression is not regulated by the Alzheimer's amyloid precursor protein intracellular domain.
by: Victoria Lewis, et al.
Published: (2012-01-01) -
Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-β or Pathologic Phenotype.
by: Isobel J Whitehouse, et al.
Published: (2016-01-01) -
Braiding braak and braak: Staging patterns and model selection in network neurodegeneration
by: Chaggar, P., et al.
Published: (2021) -
The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome
by: Yvonne S. Davidson, et al.
Published: (2018-07-01)